Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
11/2012
11/21/2012CN102190644B Chiral 3-hydroxypyridin-4-one derivatives, synthesis and application thereof
11/21/2012CN102166340B Chinese medicine composition for treating sthenia heat edema
11/21/2012CN102144958B Notoginsenoside-containing medicinal toothpaste and preparation method thereof
11/21/2012CN101933962B Ligusticum wallichii formulation granule and preparation method thereof
11/21/2012CN101873863B A botanical extract from the aqueous stream of the palm oil milling process for the prevention and inhibition of oxidative stress and haemolysis in human red blood cells
11/21/2012CN101732486B Health-preserving wine
11/21/2012CN101588819B Factor ix moiety-polymer conjugates having a releaseable linkage
11/21/2012CN101559168B Pharmaceutical composition for invigorating Qi, tonifying blood and nourishing liver and kidney as well as preparation method and application thereof
11/21/2012CN101535329B Derivatives of 5-thioxylopyranose and use of same for treatment
11/21/2012CN101273128B Platelet aggregation inhibitor composition
11/21/2012CN101163490B Artificial cerebrospinal fluid
11/20/2012US8314211 Tissue sealant for use in non compressible hemorrhage
11/20/2012CA2584406C Lecithinized superoxide dismutase composition and a process for its production
11/20/2012CA2398983C Pharmaceutical composition to prevent tissue damage due to arterial blood flow failure
11/15/2012WO2012153620A1 Drug, functional food, method for stabilizing target protein, fused protein, nucleic acid, and recombinant
11/15/2012WO2012152953A1 Methods to reduce adverse events caused by pharmaceutical preparations comprising plasma derived proteins
11/15/2012WO2012152918A1 Semuloparin for the prevention of venous thromboembolism in cancer patients receiving chemotherapy
11/15/2012WO2012109065A9 Treatment and prevention of cardiovascular disease and thrombosis
11/15/2012US20120289593 Methods for risk assessment, treating, and diagnosing myocardial infarction
11/15/2012US20120289587 Compounds that modulate intracellular calcium
11/15/2012US20120289552 Aryl ureas with angiogenesis inhibiting activity
11/15/2012US20120289551 Mineralocorticoid receptor antagonists
11/15/2012US20120289498 Compositions And Methods Relating To Novel Compounds And Targets Thereof
11/15/2012US20120289474 3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO-[4,3-c] ISOQUINOLINE DERIVATIVES
11/15/2012US20120289468 Von willebrand factor (vwf)-containing preparations, and methods, kits, and uses related thereto
11/15/2012US20120289452 Compositions and methods for treating and preventing necrosis
11/15/2012US20120288569 Parenteral administration of pyrophosphate for prevention or treatment of phosphate or pyrophosphate depletion
11/15/2012US20120288532 Multi-layered, multiple unit pharmaceutical compositions
11/15/2012US20120288531 pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof
11/15/2012US20120288504 Antagonists of il-6 to prevent or treat thrombosis
11/15/2012US20120288493 Method of inhibitng complement activation with human anti-factor c3 antibodies and use thereof
11/14/2012EP2522666A1 Imino derivatives, process for preparation thereof, and insecticides containing same
11/14/2012EP2522354A1 Methods to reduce adverse events caused by pharmaceutical preparations comprising plasma derived proteins
11/14/2012EP2521566A2 Fibrinogen preparations enriched in fibrinogen with an extended alpha chain
11/14/2012CN1675250B Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation
11/14/2012CN1668721B Immunoadhesin comprising a glycoprotein VI domain
11/14/2012CN1434795B Acyl pseudodipeptides which carry a functionalised auxiliary arm
11/14/2012CN102781930A Novel anti-platelet agent
11/14/2012CN102781324A Anti-coagulant infusion fluid source
11/14/2012CN102776129A Isaria cretacea and application thereof
11/14/2012CN102776101A Mung bean spirit prepared from crystal sugar
11/14/2012CN102776095A Mulberry wine and preparation method thereof
11/14/2012CN102775421A Hydrochloride of 2-hydroxy tetrahydrothienopyridine derivatives, and preparation method and medical application thereof
11/14/2012CN102775408A Stable amorphous 5-methyltetrahydrofolate salt and preparation method thereof
11/14/2012CN102775407A Stable 5-methyltetrahydrofolate crystal form and preparation method thereof
11/14/2012CN102772785A Composite medicine and ointment for hemostasis and preparation methods of composite medicine and ointment
11/14/2012CN102772773A Tablets for promoting circulation of Qi and inducing diuresis
11/14/2012CN102772767A Group of tablets for warming middle-Jiao and tonifying deficiency
11/14/2012CN102772749A Fushen-wild jujube tablets
11/14/2012CN102772742A Traditional Chinese medicine decoction for treating yin-deficiency epistaxis
11/14/2012CN102772735A Bupleunum-Fructus Aurantii Immaturus-Radix Curcuma-buckwheat plaster
11/14/2012CN102772704A Medicament for treating geriatric disease
11/14/2012CN102772685A Traditional Chinese medicinal preparation for treating aplastic anemia
11/14/2012CN102772653A Tablets for nourishing yin and tonifying blood
11/14/2012CN102772629A Tablet for soothing nerves and relieving restlessness
11/14/2012CN102772622A China rose medicinal liquor
11/14/2012CN102772620A Medicine for inhibiting recurrence of cancer after surgery
11/14/2012CN102772584A Folium isatidis-Chinese angelica tablets
11/14/2012CN102772562A Medicine for treating anaphylactoid purpura
11/14/2012CN102772559A Traditional Chinese medicine soup for treating anemia
11/14/2012CN102772556A Pathogenic fire and toxin clearing tablet
11/14/2012CN102772526A Health care product capable of clearing thrombus and blood poison and producing method
11/14/2012CN102772522A Traditional Chinese medicine decoction for treating liver-fire epistaxis
11/14/2012CN102772510A Folk prescription for treating anaphylactoid purpura
11/14/2012CN102772457A Total flavones extraction technology for osbeckia opipara
11/14/2012CN102772430A Hemostatic plaster
11/14/2012CN102772389A Water-soluble vitamin E soft capsule and preparation method thereof
11/14/2012CN102772307A Body gel
11/14/2012CN102771766A Tricholoma matsutake health-care product containing traditional Chinese medicine extractives and preparation method of tricholoma matsutake health-care product containing traditional Chinese medicine extractives
11/14/2012CN102327288B Blood platelet freeze-dried powder preparation for injection and preparation method thereof
11/14/2012CN102220216B Acanthopanax sessiliflorus white spirit and brewing method thereof
11/14/2012CN102100773B Low dosage burnet root solid preparation
11/14/2012CN102038713B Method of producing a dry earthworm powder
11/14/2012CN101953812B Lansoprazole enteric coated tablet and preparation method thereof
11/14/2012CN101879169B Compound preparation for treating relevant vascular diseases and preparation method thereof
11/13/2012US8309609 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
11/13/2012US8309512 Platelet aggregation inhibitor composition
11/08/2012WO2012151575A2 A method of controlling coagulation
11/08/2012WO2012151452A1 Pyruvate kinase activators for use in therapy
11/08/2012WO2012151451A1 Pyruvate kinase activators for use in therapy
11/08/2012WO2012151450A1 Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia
11/08/2012WO2012151448A1 Pyruvate kinase activators for use in therapy
11/08/2012WO2012151440A1 Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia
11/08/2012WO2012151420A1 2α-METHYL AND 2β-METHYL ANALOGS OF 19,26-DINOR-1α, 25-DIHYDROXYVITAMIN D3 AND THEIR USES
11/08/2012WO2012124973A3 Combined formulation with improved stability
11/08/2012WO2012121971A3 Locally released growth factors to mediate motor recovery after stroke
11/08/2012WO2012068381A8 Protection of renal tissues from ischemia through inhibition of the proliferative kinases cdk4 and cdk6
11/08/2012US20120283329 S isomers of alpha-methyl hydrocinnamic acid for the treatment of blood disorders
11/08/2012US20120283325 Excipient compatibility with ezatiostat
11/08/2012US20120283305 Cysteine protease inhibitors
11/08/2012US20120283303 Use of n-aminoimidazole cytoprotective compounds for treating cell death and/or gsk-3 mediated diseases
11/08/2012US20120283300 Use of benzo-heterocycle derivatives for preventing and treating cancer or for inhibiting cancer metastasis
11/08/2012US20120283255 Urea derivatives, methods for their manufacture, and uses therefor
11/08/2012US20120283238 Irak inhibitors and uses thereof
11/08/2012US20120283236 Porphyrin Catalysts and Methods of Use Thereof
11/08/2012US20120283229 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
11/08/2012US20120283169 Pharmaceutical composition, methods for treating and uses thereof
11/08/2012US20120283168 Template-fixed peptidomimetics with ccr10 antagonistic activity
11/08/2012US20120282353 Methods, compositions and articles of manufacture for hif modulating compounds
11/08/2012US20120282352 Phosphate-binding magnesium salts and uses thereof
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 671